Trial Outcomes & Findings for Study Evaluating OsseoSpeed™ Narrow Implant in the Upper and Lower Anterior Jaw (NCT NCT00646113)
NCT ID: NCT00646113
Last Updated: 2019-11-18
Results Overview
Overall implant survival rate evaluated clinically and radiographically
Recruitment status
COMPLETED
Study phase
NA
Target enrollment
72 participants
Primary outcome timeframe
Evaluated at implant placement and at the 5 years follow-up after implant placement
Results posted on
2019-11-18
Participant Flow
Unit of analysis: Implants
Participant milestones
| Measure |
OsseoSpeed™ TX 3.0
OsseoSpeed™ TX 3.0 mm diameter implants (lengths 11 mm, 13 mm and 15 mm).
|
|---|---|
|
Overall Study
STARTED
|
69 97
|
|
Overall Study
COMPLETED
|
61 86
|
|
Overall Study
NOT COMPLETED
|
8 11
|
Reasons for withdrawal
| Measure |
OsseoSpeed™ TX 3.0
OsseoSpeed™ TX 3.0 mm diameter implants (lengths 11 mm, 13 mm and 15 mm).
|
|---|---|
|
Overall Study
Lost to Follow-up
|
5
|
|
Overall Study
Adverse Event
|
3
|
Baseline Characteristics
Study Evaluating OsseoSpeed™ Narrow Implant in the Upper and Lower Anterior Jaw
Baseline characteristics by cohort
| Measure |
OsseoSpeed™ TX 3.0S
n=97 Implants
OsseoSpeed™ TX 3.0 mm diameter
|
|---|---|
|
Age, Continuous
|
32.5 years
STANDARD_DEVIATION 15.11 • n=5 Participants
|
|
Sex: Female, Male
Female
|
33 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
36 Participants
n=5 Participants
|
|
Region of Enrollment
Sweden
|
15 participants
n=5 Participants
|
|
Region of Enrollment
Denmark
|
14 participants
n=5 Participants
|
|
Region of Enrollment
United Kingdom
|
12 participants
n=5 Participants
|
|
Region of Enrollment
Italy
|
10 participants
n=5 Participants
|
|
Region of Enrollment
Germany
|
4 participants
n=5 Participants
|
|
Region of Enrollment
Spain
|
14 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Evaluated at implant placement and at the 5 years follow-up after implant placementPopulation: A total of 69 subjects were enrolled in the study and received a total of 97 implants.
Overall implant survival rate evaluated clinically and radiographically
Outcome measures
| Measure |
OsseoSpeed™
n=97 Implants
OsseoSpeed™ TX 3.0 mm diameter
|
|---|---|
|
Implant Survival Rate
|
93 Implants
|
Adverse Events
OsseoSpeed™ TX 3.0S
Serious events: 0 serious events
Other events: 39 other events
Deaths: 0 deaths
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
OsseoSpeed™ TX 3.0S
n=69 participants at risk
OsseoSpeed™ TX 3.0 mm diameter
|
|---|---|
|
Product Issues
Crown loss
|
14.5%
10/69 • Number of events 10 • 5 years
|
|
Product Issues
Abutment fractures
|
10.1%
7/69 • Number of events 7 • 5 years
|
|
Product Issues
Implant lost
|
5.8%
4/69 • Number of events 4 • 5 years
|
|
Infections and infestations
Common cold
|
20.3%
14/69 • Number of events 30 • 5 years
|
|
General disorders
Headache
|
5.8%
4/69 • Number of events 8 • 5 years
|
Additional Information
Manager Global Clinical Research
Dentsply Sirona Implants, Mölndal, SWEDEN
Phone: 0046313763500
Email: [email protected]
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60